Sorafenib for Hepatopulmonary Syndrome

Mise à jour : Il y a 4 ans
Référence : NCT02021929

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The main purpose of this clinical trial is to determine the safety and effects of the study drug, sorafenib, in adults diagnosed with hepatopulmonary syndrome (HPS). The study will evaluate how well the drug is tolerated and its effect on the level of oxygen in the blood and the function of the lung vessels.


Critère d'inclusion

  • Hepatopulmonary Syndrome

Liens